We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breaking the 1 Angstrom Imaging Barrier

By Biotechdaily staff writers
Posted on 08 Apr 2004
A new 200 kv transmission electron microscope (TEM) allows images for the first time to be directly viewed with a resolution of less than one angstrom, using commercially available technologies.

One angstrom is one-tenth of a nanometer in size, and a nanometer is one billionth of a meter. More...
One angstrom is also about one-third the size of a carbon atom and is a key dimension for atomic-level research. Now, scientists at FEI Company (Hillsboro, OR, USA) have broken the 1 angstrom high resolution imaging barrier with this new microscope.

The ability to attain direct artifact-free images of atoms opens the doors for researchers working in nanotechnology development to explore materials at the highest resolution ever. The sub-Angstrom resolution was achieved by using FEI's Tecnai F20 transmission electron microscope employing technologies that improve image resolution with advanced electron optics capabilities developed by FEI and its partner, CEOS Company (Corrected Electron Optical Systems, Heidelberg, Germany). This permits novel TEM techniques, such as 3D reconstruction with tomography, scanning probe applications, or in situ observation of specimen responses to variations in temperature, stress, or chemical environment--all with sub-Angstrom resolutions.

"The successful use of an electron beam monochromator to improve the resolution of a Cs-corrected electron microscope marks a major milestone for the field of electron microscopy,” said Dr. Michael O'Keefe of the U.S. National Center of Electron Microscopy (Berkeley, CA, USA). "Theory has long predicted that a monochromator would be able to push the resolution of the super-twin lens beyond the 1.4A resolution demonstrated with the Cs-correction alone.”

FEI Company provides advanced tools for a range of nanotechnology markets, including materials science, life science, semiconductors, and data storage. Its products enable researchers and manufacturers to fabricate and modify nanoscale structures and to view and characterize them in three dimensions down to the atomic level.




Related Links:
FEI Company

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Industry

view channel
Image: The acquisition of Exosome Diagnostics adds the ExoDx Prostate test to Mdxhealth’s portfolio (Photo courtesy of Bio-Techne)

Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.